The recognition of EZH2, EGF, and AKT1 as pivotal toxicological targets in PCBs-mediated breast carcinogenesis provides critical insights into the molecular pathways through which PCBs facilitate tumor progression. The gene discussed is EGF; the disease is neoplasm.